Healthcare

Request for TOC Request for Sample
BUY NOW

Africa Point-Of-Care Diagnostics Market – Industry Trends and Forecast to 2028

Healthcare | Published Report | May 2021 | Country Level | 350 Pages | No of Tables: 172 | No of Figures: 36

Report Description

Africa Point-Of-Care Diagnostics Market, By Type (Devices, Consumables and Kits, Software and Services, Accessories), Platform (Lateral Flow Assays /Immunochromatography Tests, Molecular Diagnostics, Immunoassays, Dipsticks, Microfluidics), End User (Professional Diagnostic Centers, Home Care, Research Laboratories, Other End Users), Distribution Channel (Direct Tender, Retail Sales), Country (Kenya, Algeria, Nigeria, Morocco, Rwanda, Zambia, Uganda, Central African Republic, Chad, Ethiopia, Mauritania, Cameroon, Angola, Libya, DRC, Ghana, Malawi) Industry Trends and Forecast to 2028

Market Analysis and Insights: Africa Point-Of-Care Diagnostics Market

The Point of care diagnostics market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing at a CAGR of 5.7% in the forecast period of 2021 to 2028 and is expected to reach USD 816.12 million by 2028. Increasing prevalence of chronic diseases and rising preference for homecare testing are anticipated to drive the growth of the market.

The Point-of-care diagnostics is characterized as a testing which can be done in close proximity to the patient where a medical decision can be made immediately including the results and monitoring. Point-of-care diagnostics is also called with-patient testing and allows physicians to accurately measure real-time, lab-quality diagnostic results within less than minutes as compared to hours. It ensures patients to receive the most effective and efficient care when and wherever needed. Additionally, Point-of-care diagnostics enables staff to make rapid decisions of treatments when diagnosing patients’ condition and the Point-of-care diagnostics simplifying the testing process.

The major factors driving the point-of-care diagnostics market's growth are increasing liver, kidney diseases and emerging point-of-care diagnostics technologies. The factor that affects the point-of-care diagnostics market from growing is the high cost of equipment and stringent government regulations.

The Point-of-care diagnostics market provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Get Exclusive Sample Copy of this Report Here

Africa Point-Of-Care Diagnostics Market Scope and Market size

The Point-of-care diagnostics market is segmented on the basis of type, platform, end user and distribution channel.

  • On the basis of type, the Point-of-care diagnostics market is segmented into devices, software and services, consumables and kits, and accessories. In 2021, the devices segment in the point-of-care diagnostics market is expected to grow due to changing lifestyles and increasing chronic diseases, and a lack of awareness of over-the-counter point-of-care diagnostics devices.
  • On the basis of platform, the point-of-care diagnostics market is segmented into lateral flow assays (immunochromatography tests), dipsticks, microfluidics, molecular diagnostics, immunoassays. In 2021, the lateral flow assays/immunochromatography tests segment in the point-of-care diagnostics market is expected to grow due to advanced technologies and inventions.
  • On the basis of end user, the point-of-care diagnostics market is segmented into professional diagnostic centers, home care, research laboratories and other end users. In 2021, the professional diagnostic centers segment in the point-of-care diagnostics market is expected to grow due to growing patient emphasis on diagnosis operations. However, the high investment cost may hamper the Point-of-care diagnostics market growth.
  • On the basis of distribution channel, the point-of-care diagnostics market is segmented into direct tender and retail sales. In 2021, the distribution channel segment in point-of-care diagnostics market is expected to grow due to the increased demand for advanced technologies and testing requirements in medical care for operations and diagnosis.

Get Exclusive Sample Copy of this Report Here

Point-Of-Care Diagnostics Market Country Level Analysis

The point-of-care diagnostics market is analysed and market size information is provided by type, platform, end user, distribution channel.

The countries covered in the point-of-care diagnostics market report are Kenya, Algeria, Nigeria, Morocco, Rwanda, Zambia, Uganda, Central African Republic, Chad, Ethiopia, Mauritania, Cameroon, Angola, Libya, DRC, Ghana, Malawi.

Kenya is expected to dominate the market due to the increasing liver, kidney diseases and emerging point-of-care diagnostics technologies.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Africa brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

New product Launches by Manufactures is Creating New Opportunities for Players in the Point-Of-Care Diagnostics Market

Point-of-care diagnostics market also provides you with detailed market analysis for every country growth in aesthetic industry with Point-of-care diagnostics market sales, impact of advancement in the Point-Of-Care Diagnostics Market and changes in regulatory scenarios with their support for the Point-of-care diagnostics market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Point-Of-Care Diagnostics Market Share Analysis

Point-of-care diagnostics market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to Point-of-care diagnostics market.

The major players covered in the Point-of-care diagnostics market report are BioTech Africa, Medtronic, Bio-Rad Laboratories, Inc., PTS Diagnostics, Trinity Biotech, Atlas Medical Uk, Abbott, Sysmex Corporation, bioMérieux SA, Quidel Corporation, BD, Sekisui Diagnostics, F. Hoffmann-La Roche Ltd, Beckman Coulter, Inc., ACON Laboratories, Inc., Nova Biomedical, Siemens Healthcare S.A.E. (a subsidiary of Siemens Healthineers AG), Instrumentation Laboratory, Abaxis, and Radiometer Medical ApS (a subsidiary of Danaher) among others. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the Point-of-care diagnostics market.

For instance,

  • In August 2020, Siemens Healthcare Private Limited has announced that they have agreed to the acquisition of the company named Varian to enhance the fight against cancer and for strengthening their business in the healthcare sector. It will help the company in the enhancement of its credibility in the market.
  • In September 2020, Instrumentation Laboratory received clearance from Food and Drug Administration (FDA) for its HemosIL Liquid Anti-Xa test kit for its de novo marketing. This test is also the first direct, oral anti-coagulant test to carry out automated homeostasis. This will help in the growth of the market in coming years.

Collaboration, joint ventures and other strategies by the market players is enhancing the company market in the Point-of-care diagnostics market which also provides the benefit for organisation to improve their offering for Point-of-care diagnostics market.


SKU-

Table of Content

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF AFRICA POINT-OF-CARE DIAGNOSTICS MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7 MULTIVARIATE MODELLING

2.8 DISTRIBUTION CHANNEL LIFELINE CURVE

2.9 DBMR MARKET POSITION GRID

2.1 VENDOR SHARE ANALYSIS

2.11 SECONDARY SOURCES

2.12 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW

5.1 DRIVERS

5.1.1 INCREASING PREVALENCE OF CHRONIC DISEASES

5.1.2 IMPROVING DIAGNOSIS SEEKING RATE

5.1.3 GROWING POPULARITY OF WEARABLE AND PORTABLE GLUCOSE MONITORING DEVICES

5.1.4 RISING PREFERENCE FOR HOMECARE TESTING

5.2 RESTRAINTS

5.2.1 PRODUCT RECALLS

5.2.2 HIGH COSTS OF PRODUCTS

5.2.3 NON-AVAILABILITY OF RELEVANT AND APPROPRIATE KITS

5.3 OPPORTUNITIES

5.3.1 STRATEGIC INITIATIVES BY THE MARKET PLAYERS

5.3.2 RISING HEALTHCARE EXPENDITURE

5.3.3 TECHNOLOGICAL ADVANCEMENTS IN POINT-OF-CARE TESTING DEVICES

5.4 CHALLENGE

5.4.1 LACK OF ALIGNMENT WITH TEST RESULTS OBTAINED FROM LABORATORIES

6 IMPACT OF COVID-19 ON THE AFRICA POINT-OF-CARE DIAGNOSTICS MARKET

6.1 IMPACT ON PRICE

6.2 IMPACT ON DEMAND

6.3 IMPACT ON SUPPLY CHAIN

6.4 KEY INITIATIVES BY MARKET PLAYERS DURING THE COVID 19

6.5 CONCLUSION:

7 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE

7.1 OVERVIEW

7.2 DEVICES

7.2.1 HEALTHCARE-ASSOCIATED INFECTION (HAI)

7.2.1.1 Respiratory infection

7.2.1.2 Tropical disease

7.2.1.3 Other infectious disease

7.2.2 HEMATOLOGY

7.2.3 CARDIAC MARKER ANALYZERS

7.2.4 URINALYSIS

7.2.5 COAGULATION

7.2.6 PREGNANCY AND FERTILITY

7.2.7 HIV

7.2.8 GLUCOSE MONITORING PRODUCTS

7.2.9 INFLUENZA

7.2.10 FECAL OCCULT

7.2.11 HEPATITIS

7.2.12 DRUGS-OF-ABUSE

7.2.13 SEXUALLY TRANSMITTED DISEASE (STD)

7.2.14 CHOLESTEROL

7.2.15 TUMOR/CANCER MARKER

7.2.16 OTHER POC PRODUCTS

7.3 CONSUMABLES AND KITS

7.3.1 GLUCOSE MONITORING STRIPS

7.3.2 HIV TEST KIT

7.3.3 LANCETS AND LANCET SYSTEMS

7.3.4 CHOLESTEROL TEST KITS

7.3.5 PREGNANCY TEST KITS

7.3.6 FERTILITY TEST KITS

7.3.7 OTHERS

7.4 SOFTWARE AND SERVICES

7.5 ACCESSORIES

8 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM

8.1 OVERVIEW

8.2 LATERAL FLOW ASSAYS /IMMUNOCHROMATOGRAPHY TESTS

8.3 MOLECULAR DIAGNOSTICS

8.4 IMMUNOASSAYS

8.5 DIPSTICKS

8.6 MICROFLUIDICS

9 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER

9.1 OVERVIEW

9.2 PROFESSIONAL DIAGNOSTIC CENTERS

9.2.1 HOSPITALS/CRITICAL CARE CENTERS

9.2.2 CLINICAL LABORATORIES, OUTPATIENT HEALTHCARE & AMBULATORY CARE SETTINGS

9.3 HOME CARE

9.4 RESEARCH LABORATORIES

9.5 OTHER END USERS

10 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL

10.1 OVERVIEW

10.2 DIRECT TENDERS

10.3 RETAIL SALES

11 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET

11.1 AFRICA

11.1.1 KENYA

11.1.2 ALGERIA

11.1.3 NIGERIA

11.1.4 MOROCCO

11.1.5 RWANDA

11.1.6 ZAMBIA

11.1.7 UGANDA

11.1.8 CENTRAL AFRICAN REPUBLIC

11.1.9 CHAD

11.1.10 ETHIOPIA

11.1.11 MAURITANIA

11.1.12 CAMEROON

11.1.13 ANGOLA

11.1.14 LIBYA

11.1.15 DRC

11.1.16 GHANA

11.1.17 MALAWI

12 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: COMPANY LANDSCAPE

12.1 COMPANY SHARE ANALYSIS: AFRICA

13 SWOT ANALYSIS

14 COMPNYA PROFILE

14.1 F. HOFFMANN-LA ROCHE LTD

14.1.1 COMPANY SNAPSHOT

14.1.2 REVENUE ANALYSIS

14.1.3 PRODUCT PORTFOLIO

14.1.4 RECENT DEVELOPMENTS

14.2 SIEMENS HEALTHCARE S.A.E. (A SUBSIDIARY OF SIEMENS HEALTHINEERS AG)

14.2.1 COMPANY SNAPSHOT

14.2.2 REVENUE ANALYSIS

14.2.3 PRODUCT PORTFOLIO

14.2.4 RECENT DEVELOPMENTS

14.3 BECKMAN COULTER, INC.

14.3.1 COMPANY SNAPSHOT

14.3.2 PRODUCT PORTFOLIO

14.3.3 RECENT DEVELOPMENTS

14.4 BD

14.4.1 COMPANY SNAPSHOT

14.4.2 REVENUE ANALYSIS

14.4.3 PRODUCT PORTFOLIO

14.4.4 RECENT DEVELOPMENTS

14.5 BIOMÉRIEUX SA

14.5.1 COMPANY SNAPSHOT

14.5.2 REVENUE ANALYSIS

14.5.3 PRODUCT PORTFOLIO

14.5.4 RECENT DEVELOPMENT

14.6 ABBOTT

14.6.1 COMPANY SNAPSHOT

14.6.2 REVENUE ANALYSIS

14.6.3 PRODUCT PORTFOLIO

14.6.4 RECENT DEVELOPMENTS

14.7 ABAXIS

14.7.1 COMPANY SNAPSHOT

14.7.2 PRODUCT PORTFOLIO

14.7.3 RECENT DEVELOPMENTS

14.8 ACON LABORATORIES, INC.

14.8.1 COMPANY SNAPSHOT

14.8.2 PRODUCT PORTFOLIO

14.8.3 RECENT DEVELOPMENTS

14.9 ATLAS MEDICAL UK

14.9.1 COMPANY SNAPSHOT

14.9.2 PRODUCT PORTFOLIO

14.9.3 RECENT DEVELOPMENTS

14.1 BIOTECH AFRICA

14.10.1 COMPANY SNAPSHOT

14.10.2 PRODUCT PORTFOLIO

14.10.3 RECENT DEVELOPMENT

14.11 BIO-RAD LABORATORIES, INC.

14.11.1 COMPANY SNAPSHOT

14.11.2 REVENUE ANALYSIS

14.11.3 PRODUCT PORTFOLIO

14.11.4 RECENT DEVELOPMENT

14.12 INSTRUMENTATION LABORATORY

14.12.1 COMPANY SNAPSHOT

14.12.2 PRODUCT PORTFOLIO

14.12.3 RECENT DEVELOPMENTS

14.13 MEDTRONIC

14.13.1 COMPANY SNAPSHOT

14.13.2 REVENUE ANALYSIS

14.13.3 PRODUCT PORTFOLIO

14.13.4 RECENT DEVELOPMENTS

14.14 NOVA BIOMEDICAL

14.14.1 COMPANY SNAPSHOT

14.14.2 PRODUCT PORTFOLIO

14.14.3 RECENT DEVELOPMENTS

14.15 PTS DIAGNOSTICS

14.15.1 COMPANY SNAPSHOT

14.15.2 PRODUCT PORTFOLIO

14.15.3 RECENT DEVELOPMENTS

14.16 RADIOMETER MEDICAL APS (A SUBSIDIARY OF DANAHER)

14.16.1 COMPANY SNAPSHOT

14.16.1 REVENUE ANALYSIS

14.16.2 PRODUCT PORTFOLIO

14.16.3 RECENT DEVELOPMENTS

14.17 SEKISUI DIAGNOSTICS

14.17.1 COMPANY SNAPSHOT

14.17.2 PRODUCT PORTFOLIO

14.17.3 RECENT DEVELOPMENT

14.18 SYSMEX CORPORATION

14.18.1 COMPANY SNAPSHOT

14.18.2 REVENUE ANALYSIS

14.18.3 PRODUCT PORTFOLIO

14.18.4 RECENT DEVELOPMENT

14.19 TRINITY BIOTECH

14.19.1 COMPANY SNAPSHOT

14.19.2 REVENUE ANALYSIS

14.19.3 PRODUCT PORTFOLIO

14.19.4 RECENT DEVELOPMENTS

14.2 QUIDEL CORPORATION

14.20.1 COMPANY SNAPSHOT

14.20.2 REVENUE ANALYSIS

14.20.3 PRODUCT PORTFOLIO

14.20.4 RECENT DEVELOPMENTS

15 QUESTIONNAIRE

16 RELATED REPORTS

List of Table

LIST OF TABLES 

TABLE 1 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019 – 2028, (USD MILLION)

TABLE 2 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019 – 2028, (UNITS)

TABLE 3 AFRICA IN POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE 2019-2028 (USD MILLION)

TABLE 4 AFRICA HEALTHCARE-ASSOCIATED INFECTION (HAI) TYPES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 5 AFRICA CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY TYPE , 2019-2028 (USD MILLION)

TABLE 6 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 7 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 8 AFRICA PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 9 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 10 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 11 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 12 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 13 AFRICA DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 14 AFRICA HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 15 AFRICA CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 16 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 17 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 18 AFRICA PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 19 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 20 KENYA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 21 KENYA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 22 KENYA DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 23 KENYA HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 24 KENYA CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 25 KENYA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 26 KENYA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 27 KENYA PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 28 KENYA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 29 ALGERIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 30 ALGERIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 31 ALGERIA DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 32 ALGERIA HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 33 ALGERIA CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 34 ALGERIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 35 ALGERIA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 36 ALGERIA PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 37 ALGERIA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 38 NIGERIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 39 NIGERIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 40 NIGERIA DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 41 NIGERIA HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 42 NIGERIA CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 43 NIGERIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 44 NIGERIA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 45 NIGERIA PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 46 NIGERIA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 47 MOROCCO POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 48 MOROCCO POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 49 MOROCCO DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 50 MOROCCO HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 51 MOROCCO CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 52 MOROCCO POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 53 MOROCCO POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 54 MOROCCO PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 55 MOROCCO POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 56 RWANDA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 57 RWANDA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 58 RWANDA DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 59 RWANDA HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 60 RWANDA CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 61 RWANDA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 62 RWANDA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 63 RWANDA PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 64 RWANDA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 65 ZAMBIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 66 ZAMBIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 67 ZAMBIA DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 68 ZAMBIA HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 69 ZAMBIA CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 70 ZAMBIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 71 ZAMBIA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 72 ZAMBIA PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 73 ZAMBIA AFRICA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 74 UGANDA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 75 UGANDA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 76 UGANDA DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 77 UGANDA HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 78 UGANDA CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 79 UGANDA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 80 UGANDA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 81 UGANDA PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 82 UGANDA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 83 CENTRAL AFRICAN REPUBLIC POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 84 CENTRAL AFRICAN REPUBLIC POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 85 CENTRAL AFRICAN REPUBLIC DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 86 CENTRAL AFRICAN REPUBLIC HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 87 CENTRAL AFRICAN REPUBLIC CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 88 CENTRAL AFRICAN REPUBLIC POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 89 CENTRAL AFRICAN REPUBLIC POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 90 CENTRAL AFRICAN REPUBLIC PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 91 CENTRAL AFRICAN REPUBLIC POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 92 CHAD POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 93 CHAD POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 94 CHAD DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 95 CHAD HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 96 CHAD CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 97 CHAD POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 98 CHAD POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 99 CHAD PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 100 CHAD POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 101 ETHIOPIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 102 ETHIOPIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 103 ETHIOPIA DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 104 ETHIOPIA HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 105 ETHIOPIA CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 106 ETHIOPIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 107 ETHIOPIA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 108 ETHIOPIA PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 109 ETHIOPIA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 110 MAURITANIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 111 MAURITANIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 112 MAURITANIA DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 113 MAURITANIA HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 114 MAURITANIA CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 115 MAURITANIA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 116 MAURITANIA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 117 MAURITANIA PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 118 MAURITANIA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 119 CAMEROON POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 120 CAMEROON POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 121 CAMEROON DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 122 CAMEROON HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 123 CAMEROON CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 124 CAMEROON POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 125 CAMEROON POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 126 CAMEROON PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 127 CAMEROON POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 128 ANGOLA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 129 ANGOLA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 130 ANGOLA DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 131 ANGOLA HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 132 ANGOLA CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 133 ANGOLA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 134 ANGOLA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 135 ANGOLA PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 136 ANGOLA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 137 LIBYA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 138 LIBYA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 139 LIBYA DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 140 LIBYA HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 141 LIBYA CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 142 LIBYA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 143 LIBYA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 144 LIBYA PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 145 LIBYA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 146 DRC POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 147 DRC POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 148 DRC DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 149 DRC HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 150 DRC CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 151 DRC POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 152 DRC POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 153 DRC PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 154 DRC POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 155 GHANA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 156 GHANA POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 157 GHANA DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 158 GHANA HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 159 GHANA CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 160 GHANA POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 161 GHANA POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 162 GHANA PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 163 GHANA POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 164 MALAWI POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 165 MALAWI POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (UNITS)

TABLE 166 MALAWI DEVICES IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028, (USD MILLION)

TABLE 167 MALAWI HEALTHCARE-ASSOCIATED INFECTION (HAI) PRODUCTS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 168 MALAWI CONSUMABLES AND KITS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY PRODUCT, 2019-2028 (USD MILLION)

TABLE 169 MALAWI POINT-OF-CARE DIAGNOSTICS MARKET, BY PLATFORM, 2019-2028 (USD MILLION)

TABLE 170 MALAWI POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 171 MALAWI PROFESSIONAL DIAGNOSTIC CENTERS IN POINT-OF-CARE DIAGNOSTICS MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 172 MALAWI POINT-OF-CARE DIAGNOSTICS MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

 

List of Figure

LIST OF FIGURES 

FIGURE 1 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 2 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: DATA TRIANGULATION

FIGURE 3 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: MULTIVARIATE MODELLING

FIGURE 8 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 11 IMPROVING DIAGNOSIS SEEKING RATE AND GROWING POPULARITY OF WEARABLE AND PORTABLE GLUCOSE MONITORING DEVICES ARE EXPECTED TO DRIVE THE AFRICA POINT-OF-CARE DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE AFRICA POINT-OF-CARE DIAGNOSTICS MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF AFRICA POINT-OF-CARE DIAGNOSTICS MARKET

FIGURE 14 TOP 10 CAUSES OF DEATHS DUE TO CHRONIC INFECTIONS IN EGYPT

FIGURE 15 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY TYPE, 2020

FIGURE 16 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY TYPE, 2019-2028 (USD MILLION)

FIGURE 17 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 18 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 19 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY PLATFORM, 2020

FIGURE 20 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY PLATFORM, 2019-2028 (USD MILLION)

FIGURE 21 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY PLATFORM, CAGR (2021-2028)

FIGURE 22 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY PLATFORM, LIFELINE CURVE

FIGURE 23 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY END USER, 2020

FIGURE 24 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 25 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY END USER, CAGR (2021-2028)

FIGURE 26 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE

FIGURE 27 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 28 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

FIGURE 29 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 30 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 31 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: SNAPSHOT (2020)

FIGURE 32 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY COUNTRY (2020)

FIGURE 33 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 34 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 35 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY PRODUCT (2020-2028)

FIGURE 36 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: COMPANY SHARE 2020 (%)

 

View Infographics

LIST OF FIGURES 

FIGURE 1 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 2 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: DATA TRIANGULATION

FIGURE 3 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: DROC ANALYSIS

FIGURE 4 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: REGIONAL VS COUNTRY MARKET ANALYSIS

FIGURE 5 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 7 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: MULTIVARIATE MODELLING

FIGURE 8 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: DBMR MARKET POSITION GRID

FIGURE 9 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: VENDOR SHARE ANALYSIS

FIGURE 10 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: SEGMENTATION

FIGURE 11 IMPROVING DIAGNOSIS SEEKING RATE AND GROWING POPULARITY OF WEARABLE AND PORTABLE GLUCOSE MONITORING DEVICES ARE EXPECTED TO DRIVE THE AFRICA POINT-OF-CARE DIAGNOSTICS MARKET IN THE FORECAST PERIOD OF 2021 TO 2028

FIGURE 12 DEVICES SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE AFRICA POINT-OF-CARE DIAGNOSTICS MARKET IN 2021 & 2028

FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGE OF AFRICA POINT-OF-CARE DIAGNOSTICS MARKET

FIGURE 14 TOP 10 CAUSES OF DEATHS DUE TO CHRONIC INFECTIONS IN EGYPT

FIGURE 15 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY TYPE, 2020

FIGURE 16 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY TYPE, 2019-2028 (USD MILLION)

FIGURE 17 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY TYPE, CAGR (2021-2028)

FIGURE 18 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY TYPE, LIFELINE CURVE

FIGURE 19 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY PLATFORM, 2020

FIGURE 20 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY PLATFORM, 2019-2028 (USD MILLION)

FIGURE 21 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY PLATFORM, CAGR (2021-2028)

FIGURE 22 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY PLATFORM, LIFELINE CURVE

FIGURE 23 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY END USER, 2020

FIGURE 24 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY END USER, 2019-2028 (USD MILLION)

FIGURE 25 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY END USER, CAGR (2021-2028)

FIGURE 26 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY END USER, LIFELINE CURVE

FIGURE 27 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2020

FIGURE 28 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

FIGURE 29 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, CAGR (2021-2028)

FIGURE 30 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE

FIGURE 31 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: SNAPSHOT (2020)

FIGURE 32 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY COUNTRY (2020)

FIGURE 33 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 34 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY COUNTRY (2020 & 2028)

FIGURE 35 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: BY PRODUCT (2020-2028)

FIGURE 36 AFRICA POINT-OF-CARE DIAGNOSTICS MARKET: COMPANY SHARE 2020 (%)

 

CHOOSE LICENCE TYPE
  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19